Agent for the Selective Adjustment of Blood Lipids

Research output: Patent

Abstract

The invention relates to the medicine, namely to an agent for reducing the cholesterol and triglycerides in the blood plasma. The agent claimed comprises a nanocomposite that is a carbon-containing nanoparticles coated with the organic alkyl functional groups representing the residuals —C4H9, —C6H11, —C8H15, —C10H21, —C16H33, —C18H35. These groups are deposited by the covalent modification using diazonium salts of the general formula XC6H4N2+—Y, where X is the alkyl residual —C4H9, —C6H11, —C8H15, —C10H21, —C16H33, or C18H35, Y is the anion —HSO4, —Cl, —BF4 or —OTs. The invention provides an effective reduction of cholesterol and triglyceride presented in the blood plasma.
Original languageEnglish
Patent numberUS 20160220608 A1
IPCC07C15/00, A61K33/44, A61K9/14
Priority date8.10.13
Publication statusPublished - 4 Aug 2016

Fingerprint

Patents and inventions
Triglycerides
Blood
Cholesterol
Lipids
Plasmas
Reducing Agents
Functional groups
Medicine
Anions
Nanocomposites
Carbon
Salts
Nanoparticles

Cite this

Postnikov, P. S., Filimonov, V. D., & Trusova, M. E. (2016). IPC No. C07C15/00, A61K33/44, A61K9/14. Agent for the Selective Adjustment of Blood Lipids. (Patent No. US 20160220608 A1).
Postnikov, PS, Filimonov, VD & Trusova, ME 2016, Agent for the Selective Adjustment of Blood Lipids, Patent No. US 20160220608 A1, IPC No. C07C15/00, A61K33/44, A61K9/14.
@misc{b3e5c2c490c2491eae999d2d4bd00c9b,
title = "Agent for the Selective Adjustment of Blood Lipids",
abstract = "The invention relates to the medicine, namely to an agent for reducing the cholesterol and triglycerides in the blood plasma. The agent claimed comprises a nanocomposite that is a carbon-containing nanoparticles coated with the organic alkyl functional groups representing the residuals —C4H9, —C6H11, —C8H15, —C10H21, —C16H33, —C18H35. These groups are deposited by the covalent modification using diazonium salts of the general formula XC6H4N2+—Y, where X is the alkyl residual —C4H9, —C6H11, —C8H15, —C10H21, —C16H33, or C18H35, Y is the anion —HSO4, —Cl, —BF4 or —OTs. The invention provides an effective reduction of cholesterol and triglyceride presented in the blood plasma.",
author = "Postnikov, {Pavel Sergeevich} and Filimonov, {Victor Dmitrievich} and Trusova, {Marina Evgenievna}",
year = "2016",
month = "8",
day = "4",
language = "English",
type = "Patent",
note = "US 20160220608 A1; C07C15/00, A61K33/44, A61K9/14",

}

TY - PAT

T1 - Agent for the Selective Adjustment of Blood Lipids

AU - Postnikov, Pavel Sergeevich

AU - Filimonov, Victor Dmitrievich

AU - Trusova, Marina Evgenievna

PY - 2016/8/4

Y1 - 2016/8/4

N2 - The invention relates to the medicine, namely to an agent for reducing the cholesterol and triglycerides in the blood plasma. The agent claimed comprises a nanocomposite that is a carbon-containing nanoparticles coated with the organic alkyl functional groups representing the residuals —C4H9, —C6H11, —C8H15, —C10H21, —C16H33, —C18H35. These groups are deposited by the covalent modification using diazonium salts of the general formula XC6H4N2+—Y, where X is the alkyl residual —C4H9, —C6H11, —C8H15, —C10H21, —C16H33, or C18H35, Y is the anion —HSO4, —Cl, —BF4 or —OTs. The invention provides an effective reduction of cholesterol and triglyceride presented in the blood plasma.

AB - The invention relates to the medicine, namely to an agent for reducing the cholesterol and triglycerides in the blood plasma. The agent claimed comprises a nanocomposite that is a carbon-containing nanoparticles coated with the organic alkyl functional groups representing the residuals —C4H9, —C6H11, —C8H15, —C10H21, —C16H33, —C18H35. These groups are deposited by the covalent modification using diazonium salts of the general formula XC6H4N2+—Y, where X is the alkyl residual —C4H9, —C6H11, —C8H15, —C10H21, —C16H33, or C18H35, Y is the anion —HSO4, —Cl, —BF4 or —OTs. The invention provides an effective reduction of cholesterol and triglyceride presented in the blood plasma.

M3 - Patent

M1 - US 20160220608 A1

ER -